Nov 4, 2025 07:10AM

Nov 4, 2025 07:09AM

Mar 27, 2025 04:05PM

Feb 6, 2025 03:18PM

Feb 6, 2025 07:30AM

Feb 6, 2025 07:30AM

Dec 9, 2024 07:31AM Relmada Therapeutics (RLMD) to Discontinue the Reliance II and Relight Phase 3 Studies of REL-1017

Dec 9, 2024 07:30AM

Jul 26, 2023 09:00PM

Mar 23, 2022 04:05PM

Aug 10, 2021 04:39PM

Aug 10, 2021 04:05PM

Jul 20, 2021 08:17AM

Jul 20, 2021 08:15AM Relmada Therapeutics Announces the Acquisition of Development and Commercial Rights to Novel Psilocybin and Derivates Program from Arbormentis LLC

Dec 16, 2019 09:23AM

Apr 3, 2018 08:00AM

Apr 21, 2016 09:00AM

Jan 26, 2016 07:00AM

Dec 28, 2015 08:30AM

Dec 7, 2015 07:45AM

Jun 11, 2015 10:46AM BioAdvance Portfolio Companies Attract $85 Million of Capital in 12 Months

Jun 1, 2015 08:32PM

1,122,779 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All